Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantat...
Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study
About this item
Full title
Author / Creator
Van Den Neste, E , Schmitz, N , Mounier, N , Gill, D , Linch, D , Trneny, M , Bouadballah, R , Radford, J , Bargetzi, M , Ribrag, V , Dührsen, U , Ma, D , Briere, J , Thieblemont, C , Bachy, E , Moskowitz, C H , Glass, B and Gisselbrecht, C
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
In the CORAL study, 255 chemosensitive relapses with diffuse large B-cell lymphoma (DLBCL) were consolidated with autologous stem cell transplantation (ASCT), and 75 of them relapsed thereafter. The median time between ASCT and progression was 7.1 months. The median age was 56.1 years; tertiary International Prognosis Index (tIPI) observed at relap...
Alternative Titles
Full title
Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1868327040
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1868327040
Other Identifiers
ISSN
0268-3369
E-ISSN
1476-5365
DOI
10.1038/bmt.2016.213
